Similar articles

• Axillary recurrence in breast cancer patients with isolated tumor cells in the sentinel lymph node [AJCC N0(i+)].

  Degnim AC, Zakaria S, Boughey JC, Sookhan N, Reynolds C, Donohue JH, Farley DR, Grant CS, Hoskin T. Degnim AC, et al. Ann Surg Oncol. 2010 Oct;17(10):2685-9. doi: 10.1245/s10434-010-1062-8. Ann Surg Oncol. 2010. PMID: 20390457
• Micrometastases in sentinel lymph nodes: few data make for hard decisions.

  Rowan K. Rowan K. J Natl Cancer Inst. 2009 Oct 21;101(20):1374-6. doi: 10.1093/jnci/djp364. Epub 2009 Oct 1. J Natl Cancer Inst. 2009. PMID: 19797724 No abstract available.
• Number of lymph nodes removed in sentinel lymph node-negative breast cancer patients is significantly related to patient age and tumor size: a new source of bias in morbidity assessment?

  Port ER, Patil S, Stempel M, Morrow M, Cody HS 3rd. Port ER, et al. Cancer. 2010 Apr 15;116(8):1987-91. doi: 10.1002/cncr.24964. Cancer. 2010. PMID: 20151427
• Lymph node staging surgery and breast cancer: potholes in the fast lane from more to less.

  Moffat FL Jr. Moffat FL Jr. J Surg Oncol. 2005 Feb 1;89(2):53-60. doi: 10.1002/jso.20118. J Surg Oncol. 2005. PMID: 15660377 Review. No abstract available.
• Avoidance of axillary lymph node dissection in selected patients with node-positive breast cancer.

  Noguchi M. Noguchi M. Eur J Surg Oncol. 2008 Feb;34(2):129-34. doi: 10.1016/j.ejso.2007.03.026. Epub 2007 May 11. Eur J Surg Oncol. 2008. PMID: 17498911 Review.